Letter to the Editor in response to the article "Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis"

被引：0
|
作者：
Farag, Youssef M. K. [1 ]
Zheng, Zihe [1 ]
Luo, Wenli [1 ]
机构：
[1] Akebia Therapeut Inc, 245 First St, Cambridge, MA 02142 USA
来源：
PHARMACOLOGICAL RESEARCH | 2021年 / 163卷
关键词：
D O I：
10.1016/j.phrs.2020.105213
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients
    Zuo, Qianwei
    Wang, Taizhong
    Zhu, Lirong
    Li, Xiao
    Luo, Qi
    RENAL FAILURE, 2022, 44 (01) : 94 - 102
  • [22] Use of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Agents for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Eshaghpour, Ali
    Foote, Rachel
    Phillips, Anna
    Sreeraman, Shreyas
    Li, Allen
    Crowther, Mark
    BLOOD, 2022, 140 : 11045 - 11046
  • [23] Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis
    Min Li
    Jiarong Lan
    Feixia Dong
    Peixin Duan
    European Journal of Clinical Pharmacology, 2021, 77 : 491 - 507
  • [24] Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis
    Li, Min
    Lan, Jiarong
    Dong, Feixia
    Duan, Peixin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (04) : 491 - 507
  • [25] Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
    Liu, Chao
    Fu, Zhangning
    Jiang, Jiawei
    Chi, Kun
    Geng, Xiaodong
    Mao, Zhi
    Song, Chengcheng
    Sun, Guannan
    Hong, Quan
    Cai, Guangyan
    Chen, Xiangmei
    Sun, Xuefeng
    FRONTIERS IN MEDICINE, 2021, 8
  • [26] Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis
    Chen, Hsin-Yu
    Ou, Shih-Hsiang
    Huang, Chien-Wei
    Lee, Po-Tsang
    Chou, Kang-Ju
    Lin, Pei-Chin
    Su, Yi-Chia
    CLINICAL DRUG INVESTIGATION, 2021, 41 (04) : 341 - 351
  • [27] Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis
    Hsin-Yu Chen
    Shih-Hsiang Ou
    Chien-Wei Huang
    Po-Tsang Lee
    Kang-Ju Chou
    Pei-Chin Lin
    Yi-Chia Su
    Clinical Drug Investigation, 2021, 41 : 341 - 351
  • [28] The efficacy and safety of molidustat for anemia in dialysis-dependent and non-dialysis-dependent chronic kidney disease patients: A systematic review and meta-analysis
    Kang, Yi
    Zhou, Mengqi
    Jin, Qian
    Geng, Yun Ling
    Wang, Yaoxian
    Lv, Jie
    HELIYON, 2024, 10 (09)
  • [29] Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
    Jia, Linpei
    Dong, Xingtong
    Yang, Jingyan
    Jia, Rufu
    Zhang, Hongliang
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)
  • [30] Efficacy and safety of hypoxia-inducible factor-prolyl hydroxylase inhibitor treatment for anemia in chronic kidney disease: an umbrella review of meta-analyses
    Ren, Song
    Yao, Xiaoxiu
    Li, Yi
    Zhang, Ying
    Tong, Chao
    Feng, Yunlin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345